Bioventis
Campus Vienna Biocenter 6
Vienna
1030
United States
Tel: 43-1-7989303
Fax: 43-1-7989303
Website: http://www.bioventis.com/
Email: uahsen@bioventis.com
3 articles about Bioventis
-
Bioventus Appoints Mary Kay Ladone to Board of Directors
7/14/2021
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has announced the appointment of Mary Kay Ladone to the Company’s Board of Directors, effective July 15, 2021
-
Bioventus Announces First Commercial Shipment of the Bioness® Integrated Therapy System (BITS) Balance SystemFourteen Facilities Across the US Receive Multidisciplinary Therapy Solution
4/27/2021
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the first commercial shipments of the Bioness Integrated Therapy System (BITS) for Balance.
-
Bioventus Reports First Patients Enrolled in Phase 1 Clinical Trial of MOTYS™ (PTP-001) for the Treatment of Knee OA
3/11/2021
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in solutions for innovative healing, reported that the first patients have been enrolled and dosed in its Phase 1 open-label, dose-escalation study of MOTYS (PTP-001) with Dr. Shailesh Patel, M.D. at Coastal Carolina Research Center, South Carolina.